| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/18/2014 | US8889133 Methods of treating diabetes with Dll4 antagonists |
| 11/18/2014 | US8889132 Antibodies against human HIF-1α |
| 11/18/2014 | US8889131 NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof |
| 11/18/2014 | US8889130 Treatment of osteoarthritis and pain |
| 11/18/2014 | US8889129 Antidotes for factor Xa inhibitors and methods of using the same |
| 11/18/2014 | US8889128 Use of the endoglycosidase endos for treating immunoglobulin G mediated diseases |
| 11/18/2014 | US8889127 Targeted protein replacement for the treatment of lysosomal storage disorders |
| 11/18/2014 | US8889124 Tolerogenic populations of dendritic cells |
| 11/18/2014 | US8889121 Bacterium comprising a regulated rfaH nucleic acid |
| 11/18/2014 | US8889118 Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
| 11/18/2014 | US8889117 Modular nanoparticles for adaptable vaccines |
| 11/13/2014 | US20140335549 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 11/13/2014 | US20140335162 Pharmaceutical composition for treatment of allergic reactions |
| 11/13/2014 | US20140335129 Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| 11/13/2014 | US20140335128 Adenoviral vector-based malaria vaccines |
| 11/13/2014 | US20140335127 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 11/13/2014 | US20140335125 Attenuated and adapted strain of pseudomonas for delivering antigens |
| 11/13/2014 | US20140335124 Recombinant Trivalent Vaccine Against Human Influenza |
| 11/13/2014 | US20140335120 Dual delivery system for heterologous antigens |
| 11/13/2014 | US20140335119 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL |
| 11/13/2014 | US20140335118 Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs) |
| 11/13/2014 | US20140335112 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 11/13/2014 | US20140335111 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |
| 11/13/2014 | US20140335110 Laser-based vaccine adjuvants |
| 11/13/2014 | US20140335105 Methods of generating hyper inos expressing cells and uses thereof |
| 11/13/2014 | US20140335100 Therapy-enhancing glucan |
| 11/13/2014 | US20140335095 Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response |
| 11/13/2014 | US20140335091 Anti-glucagon receptor antibodies and methods of use thereof |
| 11/13/2014 | US20140335086 Modified heat shock protein-antigenic peptide complex |
| 11/13/2014 | US20140335082 Combination therapy comprising an mmp-14 binding protein |
| 11/13/2014 | US20140335081 Treatment For Rheumatoid Arthritis |
| 11/13/2014 | US20140335078 Use Of Complement Inhibitors To Treat Ocular Diseases |
| 11/13/2014 | US20140335077 Compositions and Methods for the Treatment of Cancer Using IGF-IR Antagonists and MAPK/ERK Inhibitors |
| 11/13/2014 | US20140335074 Methods for improving medical therapies |
| 11/13/2014 | US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 11/13/2014 | US20140335050 Methods, compositions, and kits for the treatment of cancer |
| 11/13/2014 | US20140335049 Quil a fraction with low toxicity and use thereof |
| 11/13/2014 | US20140335047 Drug delivery product and methods |
| 11/13/2014 | US20140335022 Method for patient selection |
| 11/13/2014 | US20140335014 Il-1 alpha dual variable domain immunoglobulins and uses thereof |
| 11/11/2014 | US8883995 Live attenuated influenza virus vaccines comprising microRNA response elements |
| 11/11/2014 | US8883992 Humanized anti-CD19 antibodies |
| 11/11/2014 | US8883987 Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides |
| 11/11/2014 | US8883984 Human monoclonal antibodies to CTLA-4 |
| 11/11/2014 | US8883982 Compositions and methods for increasing serum half-life |
| 11/11/2014 | US8883981 Recombinant antibody composition |
| 11/11/2014 | US8883980 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 11/11/2014 | US8883979 Anti-prolactin receptor antibody formulations |
| 11/11/2014 | US8883978 Antibodies to tumor endothelial marker 7R |
| 11/11/2014 | US8883977 MUC1 antibody |
| 11/11/2014 | US8883976 Antibodies against human tweak and uses thereof |
| 11/11/2014 | US8883974 Device for enhancing immunostimulatory capabilities of T-cells |
| 11/11/2014 | US8883973 Fc variants with altered binding to FcRn |
| 11/11/2014 | US8883966 RAB6KIFL/KIF20A epitope peptide and vaccines containing the same |
| 11/11/2014 | US8883760 Cancer therapy using beta glucan and antibodies |
| 11/11/2014 | US8883758 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 11/11/2014 | US8883745 C—glycolipids with enhanced Th-1 profile |
| 11/11/2014 | US8883737 Methods of treating cancer |
| 11/11/2014 | US8883736 Compositions and methods for treating and diagnosing cancer |
| 11/11/2014 | US8883735 Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs |
| 11/11/2014 | US8883724 Active antiangiogenic therapy |
| 11/11/2014 | US8883717 Antigenic compositions and methods |
| 11/11/2014 | US8883500 Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy |
| 11/11/2014 | US8883481 Reverse genetics methods for virus rescue |
| 11/11/2014 | US8883480 Antiviral peptide against avian influenza virus H9N2 |
| 11/11/2014 | US8883479 Method for production of pH stable enveloped viruses |
| 11/11/2014 | US8883448 Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes |
| 11/11/2014 | US8883447 Anti-GLP-1R antibodies and their uses |
| 11/11/2014 | US8883431 Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis |
| 11/11/2014 | US8883429 Viral diagnostics |
| 11/11/2014 | US8883173 Synthetic antigenic peptides and lipopeptides derived from Mycobacterium avium subsp. paratuberculosis |
| 11/11/2014 | US8883172 Chemically modified peptides with improved immunogenicity |
| 11/11/2014 | US8883171 Computationally optimized broadly reactive antigens for influenza |
| 11/11/2014 | US8883170 Adjuvant |
| 11/11/2014 | US8883169 Immunogen platform |
| 11/11/2014 | US8883168 Modulation of immune responses by the poxviral K4 protein |
| 11/11/2014 | US8883166 Combination vaccines with whole cell pertussis antigen |
| 11/11/2014 | US8883165 Modified peptide vaccine derived from influenza M2 |
| 11/11/2014 | US8883164 Targeted identification of immunogenic peptides |
| 11/11/2014 | US8883163 Immunogenic composition |
| 11/11/2014 | US8883162 Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors |
| 11/11/2014 | US8883161 Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant |
| 11/11/2014 | US8883159 Antibodies against CDCP1 for the treatment of cancer |
| 11/11/2014 | US8883158 Compositions and methods for antibodies targeting complement protein C5 |
| 11/11/2014 | US8883157 Targeting rare human PCSK9 variants for cholesterol treatment |
| 11/11/2014 | US8883156 Purified antibody composition |
| 11/11/2014 | US8883155 Methods for treating hematopoietic malignancies |
| 11/11/2014 | US8883154 Antibody-mediated modulation of allergy |
| 11/11/2014 | US8883153 Methods for preventing and treating angioedema |
| 11/11/2014 | US8883152 Anti-cobra toxin antibody fragments and method of producing a VH H library |
| 11/11/2014 | US8883151 IL-17 receptor antibody formulation |
| 11/11/2014 | US8883150 Soluble “heavy-chain only” antibodies |
| 11/11/2014 | US8883149 Antibody combinations and use of same for treating cancer |
| 11/11/2014 | US8883148 Prevention of joint destruction |
| 11/11/2014 | US8883147 Immunoglobulins insertions, deletions, and substitutions |
| 11/11/2014 | US8883146 Protein formulations and methods of making same |
| 11/11/2014 | US8883145 Methods of treatment with DLL4 antagonists and an anti-hypertensive agent |
| 11/11/2014 | US8883136 Methods for accelerating the healing of connective tissues injuries and disorders |
| 11/11/2014 | US8883123 Use of vaccines for the treatment/prevention of the transmission of pathogens |
| 11/06/2014 | US20140329998 Methods for making saccharide-protein glycoconjugates |